Nastran Hashemzadeh, Khosro Adibkia  , Jaleh Barar*
|
Zahra Karimzadeh, Siamak Javanbakht, Hassan Namazi*
Carboxymethylcellulose/MOF-5/Graphene
oxide bio-nanocomposite was synthesized through a solvothermal technique,
which it could encapsulate tetracycline. The drug release tests showed
the stability of drug dosing in the gastrointestinal tract conditions. Antibacterial
tests exhibited suitable activity to negatively charge E. coli bacteria.
|
Azam Safary , Rezvan Moniri, Maryam Hamzeh-Mivehroud, Siavoush Dastmalchi*
The current study introduces a new and efficient recombinant L-asparaginase (ASPase) enzyme from locally isolated halo-thermotolerant Bacillus. The activity assay of ASPase A1 and ASPase A3 showed that only ASPase A1 is an active and stable homologues enzyme with high substrate affinity toward L-asparagine.
|
Cécilia Delattre*, Diego Velazquez, Caroline Roques, Graciela Pavon-Djavid, Véronique Ollivier, Anna Lokajczyk, Thierry Avramoglou, Virginie Gueguen, Liliane Louedec, Giuseppina Caligiuri, Martine Jandrot-Perrus, Catherine Boisson-Vidal, Didier Letourneur, Anne Meddahi-Pelle
Schematic illustration of the subsequent steps for the stents coating process and the evaluation of their biocompatibility: in vitro, ex vivo and in vivo (abdominal aorta stenting and stent restenosis preclinical models) evaluation of Dex-PBMA.
|
Ramanjot Kaur, Ameya Sharma, Vivek Puri, Inderbir Singh*
Biocomposite films of biocomposite films of Carrageenan/Locust Bean Gum/Montmorillonite were prepared for the transdermal delivery of curcumin. Biocomposite films were effective in terms of physicochemical properties and were effective in wound care management.
|
Sepideh Parvizpour, Jafar Razmara, Mohammad M. Pourseif, Yadollah Omidi*
Using
immunoinformatic tools, a multi-epitope peptide vaccine (consisting of CD8+cytotoxic T lymphocytes epitopes, helper epitopes and
adjuvant) was designed to combat the triple-negative breast cancer. The vaccine
showed acceptable immunogenicity and potential to stimulate both cellular and
humoral immune responses.
|
Tatiana Matvienko, Viktoriya Sokolova, Svitlana Prylutska, Yuliia Harahuts, Nataliya Kutsevol, Viktor Kostjukov, Maxim Evstigneev* , Yuriy Prylutskyy*, Matthias Epple, Uwe Ritter
It was found that the Dextran-PNIPAM+Dox nanofluid in contrast to Dox alone showed higher toxicity towards HeLa cells, whereas the SWCNT+Dox and GO+Dox nanofluids protected cells from Dox.
|
Ananda Mookerjee, Michele Graciotti, Lana E. Kandalaft*
|